CMT Research Foundation
CMT研究基金会
CMT Research Foundation (CMTRF) is a nonprofit organization focused on advancing therapies and patient care for Charcot-Marie-Tooth disease (CMT), a hereditary neurological disorder also known as腓骨肌萎缩症 . In June 2024 it entered a strategic partnership with ReviR Therapeutics (溪砾科技) to jointly develop small-molecule RNA-targeted therapies that modulate expression of the CMT1A disease-causing gene, providing funding support for the program . The foundation also participated as a co-investor in ReviR's $30 million Series A round that closed the following month in July 2024 .
AI-generated — may contain errors, please verify.
Coverage
If wisdom lacks the courage of execution, it is all in vain | 5Y News Monthly
The big news from last month.
5Y News | 5Y Capital Portfolio Company ReviR Therapeutics Raises $30 Million in Series A Funding
Continuing to advance "oral gene therapy" through AI+RNA.
ReviR Therapeutics Receives Investment from CMT Research Foundation, Pioneering Small-Molecule RNA-Targeted Therapy for CMT1A | BlueRun Ventures Headlines
ReviR Therapeutics and the CMT Research Foundation Announce Strategic Partnership
